David Michael Clark Amicus Therapeutics, Inc. (FOLD) insider trading activity

David Michael Clark is Chief People Officer of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 253,664 shares of FOLD, which is worth approximately $2.54 Million. The most recent transaction as insider was on Feb 15, 2024, when has been sold 4,427 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $61,978. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 254K

0% 3M change

5.23% 12M change

Total Value Held $2.54 Million

David Michael Clark Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 15 2024	SELL Open market or private sale	$61,978 $14.0 p/Share	4,427 Reduced 1.72%	253,664 Common Stock
Jan 09 2024	SELL Payment of exercise price or tax liability	$117,581 $13.65 p/Share	8,614 Reduced 3.23%	258,091 Common Stock
Jan 09 2024	SELL Open market or private sale	$19,376 $14.0 p/Share	1,384 Reduced 0.52%	266,705 Common Stock
Jan 08 2024	SELL Open market or private sale	$122,164 $14.0 p/Share	8,726 Reduced 3.15%	268,089 Common Stock
Jan 04 2024	SELL Payment of exercise price or tax liability	$36,180 $13.44 p/Share	2,692 Reduced 0.96%	276,815 Common Stock
Jan 03 2024	SELL Payment of exercise price or tax liability	$157,624 $13.53 p/Share	11,650 Reduced 4.0%	279,507 Common Stock
Jan 02 2024	SELL Payment of exercise price or tax liability	$90,153 $14.24 p/Share	6,331 Reduced 2.13%	291,157 Common Stock

Jan 02 2024	BUY Grant, award, or other acquisition	-	48,209 Added 13.95%	297,488 Common Stock
Dec 18 2023	BUY Grant, award, or other acquisition	-	8,212 Added 3.19%	249,279 Common Stock
Jan 18 2023	SELL Open market or private sale	$99,657 $13.5 p/Share	7,382 Reduced 2.97%	241,067 Common Stock
Jan 11 2023	SELL Payment of exercise price or tax liability	$225,230 $12.02 p/Share	18,738 Reduced 7.01%	248,449 Common Stock
Jan 11 2023	BUY Grant, award, or other acquisition	-	47,621 Added 15.13%	267,187 Common Stock
Jan 06 2023	SELL Open market or private sale	$255,288 $11.87 p/Share	21,507 Reduced 8.92%	219,566 Common Stock
Jan 04 2023	SELL Payment of exercise price or tax liability	$32,384 $12.03 p/Share	2,692 Reduced 1.1%	241,073 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$69,313 $11.93 p/Share	5,810 Reduced 2.33%	243,765 Common Stock
Jan 03 2023	SELL Open market or private sale	$102,170 $12.03 p/Share	8,493 Reduced 4.27%	190,203 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	59,372 Added 19.22%	249,575 Common Stock
Jan 02 2023	SELL Payment of exercise price or tax liability	$138,412 $12.21 p/Share	11,336 Reduced 5.4%	198,696 Common Stock
Oct 09 2022	SELL Payment of exercise price or tax liability	$57,304 $10.4 p/Share	5,510 Reduced 2.56%	210,032 Common Stock
Aug 05 2022	SELL Open market or private sale	$141,525 $12.5 p/Share	11,322 Reduced 4.99%	215,542 Common Stock
Jan 14 2022	SELL Payment of exercise price or tax liability	$133,563 $10.53 p/Share	12,684 Reduced 5.29%	226,864 Common Stock
Jan 14 2022	BUY Grant, award, or other acquisition	-	91,306 Added 27.6%	239,548 Common Stock
Jan 04 2022	SELL Payment of exercise price or tax liability	$33,596 $12.48 p/Share	2,692 Reduced 1.78%	148,242 Common Stock
Jan 02 2022	SELL Payment of exercise price or tax liability	$123,181 $11.55 p/Share	10,665 Reduced 6.6%	150,934 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$84,084 $11.55 p/Share	7,280 Reduced 4.31%	161,599 Common Stock

DMC

David Michael Clark

Chief People Officer

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account